论文部分内容阅读
2003年,在汹涌而来的民营资本的照耀下,药业上市公司的“灵魂像起了大火般雪亮”(舒婷语)。排在2002年度福布斯中国富豪榜第36位的朱保国,在这一年里一口气吃下了丽珠集团、健康药业和济南东风药业,让那些等着看他再度上演王文京式的“不会花钱”一幕的评论者知趣地闭上了嘴。在近来的民企风波中颇受人瞩目的资本巨头复兴实业,正全力以赴与顶着SARS阴影赴港登陆H股的中国第一大零售巨头
In 2003, with the surge of private capital, the “soul of a pharmaceutical listed company was as loud as a fire” (Shu Ting). Zhu Baoguo, ranked 36th in the Forbes China Rich List in 2002, ate up Livzon Group, Health Pharmaceuticals and Jinan Dongfeng Pharmaceuticals during the year, so that those waiting to see him re-staged Wang Wenjing’s “ Do not spend money ”commentator closed his mouth in the interest of knowledge. In the recent turmoil in private enterprises, the highly regarded capital giant Fuxing Industrial is going all out to withstand the shadow of SARS landing in Hong Kong H shares of China’s largest retail giant